Having trouble viewing this email? View in your browser.
ESCMID Logo

2 May 2018
WEEKLY NEWS

Dear colleagues,

Please support ESCMID’s study group for antimicrobial stewardship ESGAP by completing a short survey on training programmes for health professionals on antimicrobial stewardship (AMS). An inventory of these training programmes will be made available to all healthcare professionals interested in AMS, as well as to WHO and ECDC.

AllGenetics, Coruña University, and the Instituto de Investigación Biomédica de A Coruña organise a DNA metabarcoding workshop from 27/28 June 2018 in A Coruña, Spain. The presentations will focus on applications including human and bioreactor microbiome as well as technical aspects of DNA metabarcoding such as the impact of reference databases, primer design, high-throughput sequencing platforms, bioinformatic pipelines. The registration is open until 6 May 2018.

Your ESCMID communications editors

 

Thank you for making ECCMID 2018 such a success!

We are proud to report that 12,949 people from 124 countries attended our annual congress ECCMID 2018 in Madrid last month. The top 10 countries of provenance were the United States, Spain, the United Kingdom, France, Germany, Italy, the Netherlands, Switzerland, Belgium, and China, which for the first time moved into the top 10. Of the 5,500 regular and late-breaking abstracts received from 116 different countries, 3,563 abstracts were presented in oral, eposter and paper poster sessions. The congress featured more than 150 sessions with invited speakers covering the entire field of infectious diseases and clinical microbiology, including eight keynote lectures, over 100 symposia and oral sessions, 22 educational workshops and 22 meet-the-expert sessions. Abstracts, presentations and webcasts from this year’s ECCMID will be freely available on ECCMID Live until the end of August. The material is currently being curated to be included in the ESCMID eLibrary, which also hosts material from other ESCMID events. You may read more about some of the highlights in the press releases on the conference website, and video clips featuring interviews with keynote speakers, session chairs and selected presenters may also be found on the society’s ECCMID 2018 Youtube channel.

› Read more
 

EUCIC participates in WHO sepsis campaign on 5 May 2018

ESCMID’s infection control committee EUCIC encourages healthcare and in particular infection prevention and control professionals to participate in this year’s World Health Organization clean hands campaign It’s in your hands – prevent sepsis in health care. WHO calls on health facilities to prevent healthcare-associated sepsis through hand hygiene and infection prevention and control (IPC) action.

› Read more
 

CMI highlight: CSF has potential for Lyme neuroborreliosis diagnosis

Rupprecht et al conducted a review to evaluate the utility of cerebrospinal fluid (CSF) CXCL13 for diagnosis of acute Lyme neuroborreliosis (LNB). They included a total of 18 studies involving 618 patients with acute LNB and 2,326 patients with other neurological disorders. The pooled sensitivity for CSF CXCL13 was 89%, and the pooled specificity was 96%, using the identified optimal cut-off value of 162 pg/mL. There was marked heterogeneity between studies, caused by differences in the designs of the study populations and age distribution. The optimal cut-off in the seven studies with a cross-sectional design was 91 pg/mL and 164 pg/mL in the 11 case-control studies. CSF CXCL13 values above the optimal cut-off level were also detectable in some other CNS disorders, namely neurosyphilis and CNS-lymphoma. The meta-analysis conducted by the researchers in Munich showed that CSF CXCL13 has the potential to become a useful adjunct in the diagnosis of acute LNB.

› Read more
 

ESCMID/ASM AMR conference registration, abstract submission open

The ESCMID/ASM conference on drug development to meet the challenge of antimicrobial resistance (AMR) will take place in Lisbon, Portugal, from 4 – 7 September 2018. The registration and the submission of abstracts on original data for poster and platform presentations are open now. The conference focusses on the development of new antimicrobial agents to tackle AMR, which remains a pressing public health problem. The multidisciplinary meeting involves basic scientists, clinical academics, regulatory bodies, funding bodies and the pharmaceutical industry. Its scope stretches from chemistry to clinical development, from neonates to adults, from bacteria to fungi – all with a global perspective. The meeting is practical, interactive with plenty of time for networking. ESCMID will support young investigators and researchers from low and middle-income countries.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.